Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATRS | MCK | BDX | WST | CAH |
| Company | Antares Pharma | Mckesson Corp | Becton Dickinson and Company | West Pharmaceutical Services | Cardinal Health |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NYSE | NYSE |
| Open | 5.58 | 543.89 | 234.14 | 367.42 | 97.36 |
| High | 5.60 | 556.46 | 236.45 | 369.22 | 98.87 |
| Low | 5.58 | 543.89 | 233.92 | 354.62 | 97.36 |
| Last | 5.59 | 555.12 | 235.00 | 365.59 | 98.06 |
| Change | unch | +11.51 | +1.42 | -1.07 | +0.62 |
| % Change | unch | +2.12% | +0.61% | -0.29% | +0.64% |
| Volume | 2,707,400 | 977,300 | 1,921,700 | 795,400 | 1,822,500 |
| 20-Day Average Volume | 3,885,230 | 756,990 | 1,374,425 | 493,760 | 2,248,370 |
| Previous Close | 5.59 | 543.61 | 233.58 | 366.66 | 97.44 |
| Industry | Medical - Dental Suppliers | Medical - Dental Suppliers | Medical - Dental Suppliers | Medical - Dental Suppliers | Medical - Dental Suppliers |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 5.57 | 533.15 | 234.18 | 371.04 | 103.03 |
| 20-Day Raw Stochastic | 83.33% | 78.71% | 40.37% | 30.80% | 6.75% |
| 20-Day Relative Strength | 76.57% | 63.72% | 47.81% | 45.02% | 34.02% |
| Weighted Alpha | +30.00 | +43.82 | -8.36 | +0.50 | +9.41 |
| Today's Opinion | 100% Buy | 100% Buy | 88% Sell | 8% Buy | 24% Sell |
| Previous Opinion | 100% Buy | 100% Buy | 100% Sell | 8% Sell | 24% Sell |
| Last Month's Opinion | 88% Buy | 80% Buy | 8% Sell | 72% Buy | 64% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.36% since 05/16/22 | +4.69% since 05/02/24 | -2.23% since 05/02/24 | -0.78% since 05/02/24 | -4.78% since 05/02/24 |
| Low | 5.57 on 05/18/22 | 520.49 on 05/03/24 | 233.18 on 05/08/24 | 354.62 on 05/09/24 | 97.31 on 05/08/24 |
| High | 5.60 on 05/23/22 | 566.01 on 05/08/24 | 242.29 on 05/03/24 | 372.79 on 05/03/24 | 102.26 on 05/03/24 |
| 1-Month | |||||
| %Chg | +0.36% since 04/22/22 | +5.28% since 04/09/24 | -4.40% since 04/09/24 | -6.83% since 04/09/24 | -9.26% since 04/09/24 |
| Low | 5.54 on 05/12/22 | 514.88 on 04/18/24 | 229.40 on 04/17/24 | 352.76 on 04/30/24 | 97.31 on 05/08/24 |
| High | 5.60 on 05/23/22 | 566.01 on 05/08/24 | 243.74 on 04/10/24 | 394.42 on 04/24/24 | 108.57 on 04/10/24 |
| 3-Month | |||||
| %Chg | +65.88% since 02/23/22 | +10.73% since 02/09/24 | -3.59% since 02/09/24 | -10.75% since 02/09/24 | -6.57% since 02/09/24 |
| Low | 3.24 on 02/24/22 | 493.97 on 02/12/24 | 229.40 on 04/17/24 | 325.73 on 02/15/24 | 97.31 on 05/08/24 |
| High | 5.60 on 05/23/22 | 566.01 on 05/08/24 | 248.42 on 03/28/24 | 409.72 on 02/12/24 | 116.04 on 03/13/24 |
| 6-Month | |||||
| %Chg | +63.93% since 11/23/21 | +20.19% since 11/09/23 | +1.19% since 11/09/23 | +8.79% since 11/09/23 | -4.62% since 11/09/23 |
| Low | 3.11 on 01/28/22 | 431.35 on 12/15/23 | 229.40 on 04/17/24 | 325.73 on 02/15/24 | 97.31 on 05/08/24 |
| High | 5.60 on 05/23/22 | 566.01 on 05/08/24 | 249.89 on 01/09/24 | 413.70 on 02/07/24 | 116.04 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 955,063 | 71,434,704 | 67,506,024 | 26,708,616 | 23,733,170 |
| Shares Outstanding, K | 170,852 | 131,408 | 289,006 | 72,843 | 243,567 |
| Annual Sales | 183,980,000 | 276,711,000,000 | 19,372,000,000 | 2,949,800,000 | 205,012,000,000 |
| Annual Net Income | 46,290,000 | 3,560,000,000 | 1,484,000,000 | 593,400,000 | 261,000,000 |
| Last Quarter Sales | 41,560,000 | 80,898,000,000 | 5,045,000,000 | 695,400,000 | 54,911,000,000 |
| Last Quarter Net Income | -2,320,000 | 589,000,000 | 537,000,000 | 115,300,000 | 258,000,000 |
| 60-Month Beta | 1.15 | 0.45 | 0.45 | 1.05 | 0.71 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.01 on 05/10/22 | 6.18 on 05/07/24 | 3.17 on 05/02/24 | 1.56 on 04/25/24 | 2.08 on 05/02/24 |
| Latest Earnings Date | 05/19/22 | 05/07/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.620 on 02/29/24 | 0.950 on 03/07/24 | 0.200 on 04/23/24 | 0.501 on 03/28/24 |
| Next Ex-Dividends Date | N/A | 05/31/24 | 06/07/24 | 07/31/24 | 03/28/24 |
| Ratios | |||||
| Price/Earnings ttm | 79.86 | 19.90 | 19.39 | 48.09 | 13.89 |